You just read:

AbbVie Presents Results from Study of ABT-414 in Patients with Glioblastoma Multiforme at the 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

News provided by

AbbVie

Nov 14, 2014, 04:48 ET